CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NanoInhale focuses on developing innovative polypeptide nanoparticles for targeted drug delivery in respiratory diseases like tuberculosis. The project aims to enhance inhalation therapies using advanced polymeric carriers to improve treatment efficacy.
Infectious respiratory diseases such as COVID or tuberculosis (TB) still have devastating effects on population health.
While the development of potent vaccines has drastically reduced infection rates for some diseases, medicinal drugs remain a corner stone of treatment.
Respiratory drug delivery via inhalation is considered an ideal way to directly target the site of infection in the lung.
However, suitable functional polymeric drug carriers meeting all clinical and pharmaceutical requirements…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
